Patent directory · USPTO A61K / A61P
Patents matching “PrimeVax Immuno-Oncology”
10 pharma patents match "PrimeVax Immuno-Oncology" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 10 pharmaceutical patents matching "PrimeVax Immuno-Oncology" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12377115
Combination immunotherapies for treatment of cancer
granted -
US 12059443
Method for treating cancer using dengue virus serotype 1 (DENV-1)
granted -
US 11357795
Combination immunotherapies for treatment of cancer
granted -
US 10946080
Compositions and methods for combination therapy with dengue virus and dendritic cells
granted -
US 10765727
Compositions and methods for producing dendritic cells
granted -
US 10675304
Combination immunotherapies for treatment of cancer
granted -
US 10357553
Compositions and methods for combination therapy with dengue virus and dendritic cells
granted -
US 10159727
Compositions and methods for combination therapy with dengue virus and dendritic cells
granted -
US 9849167
Compositions and methods for combination therapy with dengue virus and dendritic cells
granted -
US 9730989
Compositions and methods for combination therapy with dengue virus and dendritic cells
granted